These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 18159926)

  • 21. Spectroscopic investigation of the aggregation state of amphotericin B during loading, freeze-drying, and reconstitution of polymeric micelles.
    Adams M; Kwon GS
    J Pharm Pharm Sci; 2004 Nov; 7(4):1-6. PubMed ID: 15850542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Encapsulation and release of Amphotericin B from an ABC triblock fluorous copolymer.
    Jee JP; McCoy A; Mecozzi S
    Pharm Res; 2012 Jan; 29(1):69-82. PubMed ID: 21739321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro characterization of PEGylated phospholipid micelles for improved drug solubilization: effects of PEG chain length and PC incorporation.
    Ashok B; Arleth L; Hjelm RP; Rubinstein I; Onyüksel H
    J Pharm Sci; 2004 Oct; 93(10):2476-87. PubMed ID: 15349957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct interaction between amphotericin B and ergosterol in lipid bilayers as revealed by 2H NMR spectroscopy.
    Matsumori N; Tahara K; Yamamoto H; Morooka A; Doi M; Oishi T; Murata M
    J Am Chem Soc; 2009 Aug; 131(33):11855-60. PubMed ID: 19645473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of grafted PEG on liposome size and on compressibility and packing of lipid bilayer.
    Garbuzenko O; Barenholz Y; Priev A
    Chem Phys Lipids; 2005 Jun; 135(2):117-29. PubMed ID: 15921973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of DSPE-PEG
    Zhang W; Wang Z; Wu C; Jin Y; Liu X; Wu Z; Liu J
    Eur J Pharm Sci; 2018 Dec; 125():74-85. PubMed ID: 30236551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic and biodistribution studies of amphotericin B microspheres.
    Angra PK; Siddig A; Nettey H; Desai N; Oettinger C; D'Souza MJ
    J Microencapsul; 2009 Nov; 26(7):627-34. PubMed ID: 19839798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular localization and state of amphotericin B in PEG liposomes.
    Moribe K; Maruyama K; Iwatsuru M
    Int J Pharm; 1999 Dec; 193(1):97-106. PubMed ID: 10581426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PEG-phospholipid micelles for the delivery of amphotericin B.
    Vakil R; Kwon GS
    J Control Release; 2005 Jan; 101(1-3):386-9. PubMed ID: 15822230
    [No Abstract]   [Full Text] [Related]  

  • 30. Encapsulation characteristics of nystatin in liposomes: effects of cholesterol and polyethylene glycol derivatives.
    Moribe K; Maruyama K; Iwatsuru M
    Int J Pharm; 1999 Oct; 188(2):193-202. PubMed ID: 10518675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel performing PEG-cholane nanoformulation for Amphotericin B delivery.
    Luengo-Alonso C; Torrado JJ; Ballesteros MP; Malfanti A; Bersani S; Salmaso S; Caliceti P
    Int J Pharm; 2015 Nov; 495(1):41-51. PubMed ID: 26319629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Poly(ethylene glycol)-modification of the phospholipid vesicles by using the spontaneous incorporation of poly(ethylene glycol)-lipid into the vesicles.
    Sou K; Endo T; Takeoka S; Tsuchida E
    Bioconjug Chem; 2000; 11(3):372-9. PubMed ID: 10821653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The study on brain targeting of the amphotericin B liposomes.
    Zhang X; Xie J; Li S; Wang X; Hou X
    J Drug Target; 2003 Feb; 11(2):117-22. PubMed ID: 12881198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Composition-dependent structural changes and antitumor activity of ASC-DP/DSPE-PEG nanoparticles.
    Higashi K; Mibu F; Saito K; Limwikrant W; Yamamoto K; Moribe K
    Eur J Pharm Sci; 2017 Mar; 99():24-31. PubMed ID: 27916697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of hydrophilic and hydrophobic structure of amphiphilic polymeric micelles on their transport in epithelial MDCK cells.
    Yu C; He B; Xiong MH; Zhang H; Yuan L; Ma L; Dai WB; Wang J; Wang XL; Wang XQ; Zhang Q
    Biomaterials; 2013 Aug; 34(26):6284-98. PubMed ID: 23714243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics and nephrotoxicity of amphotericin B-incorporated poly(ethylene glycol)-block-poly(N-hexyl stearate l-aspartamide) micelles.
    Diezi TA; Takemoto JK; Davies NM; Kwon GS
    J Pharm Sci; 2011 Jun; 100(6):2064-70. PubMed ID: 21491436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amphotericin B-entrapping lipid nanoparticles and their in vitro and in vivo characteristics.
    Jung SH; Lim DH; Jung SH; Lee JE; Jeong KS; Seong H; Shin BC
    Eur J Pharm Sci; 2009 Jun; 37(3-4):313-20. PubMed ID: 19491021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High intensity focused ultrasound-responsive release behavior of PLA-b-PEG copolymer micelles.
    Zhang H; Xia H; Wang J; Li Y
    J Control Release; 2009 Oct; 139(1):31-9. PubMed ID: 19523500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polyethylene glycol-polyamidoamine dendritic micelle as solubility enhancer and the effect of the length of polyethylene glycol arms on the solubility of pyrene in water.
    Yang H; Morris JJ; Lopina ST
    J Colloid Interface Sci; 2004 May; 273(1):148-54. PubMed ID: 15051444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation of pluronic and PEG-PE micelles as carriers of meso-tetraphenyl porphine for oral administration.
    Sezgin Z; Yuksel N; Baykara T
    Int J Pharm; 2007 Mar; 332(1-2):161-7. PubMed ID: 17055200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.